- Joined
- Apr 15, 2012
- Messages
- 14,730
http://www.internalmedicinenews.com...duction/1a0aecf9942a538c0d9225ee8d135725.html
Methotrexate Cuts Anti-Adalimumab Antibody Production
07-11-2012 10:50
By: MITCHEL L. ZOLER, Internal Medicine News Digital Network
AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
During 3 years of follow-up, 76 patients (28%) developed a significant immune response to the adalimumab, accounting for half of those getting no methotrexate, 35% of patients on a low methotrexate dose, 22% on an intermediate dose, and 14% on a high dose.
An odds ratio analysis showed that low-dose methotrexate cut the frequency of immune responses by 64%, an intermediate dose cut the incidence of antibody production by 78%, and high dose cut the rate by 86% compared with no methotrexate, all statistically significant differences. Only high doses of methotrexate significantly cut the rate of antibody production compared with low doses.
Methotrexate Cuts Anti-Adalimumab Antibody Production
07-11-2012 10:50
By: MITCHEL L. ZOLER, Internal Medicine News Digital Network
AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY